Status:
COMPLETED
The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co.
Lead Sponsor:
Zanjan University of Medical Sciences
Conditions:
Diabetes Mellitus, Type 2 AND Metformin
Eligibility:
FEMALE
30-80 years
Phase:
PHASE4
Brief Summary
Background: Metformin is usually using for glycemic control in type 2 diabetes mellitus. Different pharmaceutical types of metformin are available. As a clinical trial, we compared the efficacy and co...
Eligibility Criteria
Inclusion
- Mild hyperglycemia, no contraindication for metformin, poor controlled diabetes
Exclusion
- Creatinine more than 1.5, severe organ damage
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT01228240
Start Date
December 1 2008
End Date
September 1 2009
Last Update
July 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.